new oral glp 1 GLP-1 Medication Helps Patients Maintain Weight Loss | Newsroom BREAKING: The FDA has approved

Estimated hazard ratio for 6 mg/weekly dose of efpeglenatide compared to placebo was 0,65 (95% CI, 0.5 to 0.86) and 0.82 (95% CI 0.63 1.06) for 4 mg/weekly dose compared to placebo (44)

doi: 10.1007/s11845-016-1464-0 111

Wait at least 30 minutes before eating, drinking or taking other tablets to allow proper absorption

Several studies have implied that FXR activation relieves intestinal inflammatory state in IBD patients, as well as that colonic inflammation in patients with CD and in rodent models of colitis is linked to diminished expression of FXR mRNA (Vavassori et al., 2009)

Aim for at least 64 ounces of water daily, more if you experience significant GI effects

Abstract Background A giant congenital melanocytic nevus (GCMN) is found in 0.1% of live-born infants